Identification of Five Serum Protein Markers for Detection of Ovarian Cancer by Antibody Arrays

Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer

(2012) E. Kobayashi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis

(2012) Denis Lane et al.   Journal of Ovarian Research

Screening for ovarian cancer in the general population

(2011) Aleksandra Gentry-Maharaj et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

(2011) C. S. Zhu et al.   Cancer Prevention Research

Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer

(2008) K. A. Lowe et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

OPG Is Regulated by  -Catenin and Mediates Resistance to TRAIL-Induced Apoptosis in Colon Cancer

(2008) E. N. De Toni et al.   CLINICAL CANCER RESEARCH

Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells

(2008) Tom Donnem et al.   Journal of Thoracic Oncology